Hepatitis C Treatment Costing a Fortune? Get Affordable Sofosbuvir/Daclatasvir in your Country

Summary - Chronic hepatitis C can be cured with direct-acting antivirals like Sofosbuvir and Daclatasvir. However, the branded combinations come with steep prices than many can’t afford. Through compliant global personal imports, MedsPartner provides access to generic Sofosbuvir/Daclatasvir at over 97% savings, making hep C meds affordable for patients worldwide. This blog explains the whole process.

Hepatitis C is curable. Twelve weeks of pills remove the virus from the body - permanently. Cure rates run above 90% for most patients. But when Sovaldi and Daklinza were first launched - U.S. list prices were steep. A 12-week course of Sovaldi costed about $84,000 and Daklinza costed ~$63,000. Combined, the total price was a whopping $150,000. 

Since then, treatment has evolved. Newer branded fixed-dose combinations such as Epclusa and Mavyret are now widely used in high-income countries. The US prices for these modern regimens still cost over $20,000.

Daclatasvir was discontinued as a branded product in the U.S. in 2019 as manufacturers shifted toward newer combinations. However, the underlying regimen of sofosbuvir plus daclatasvir remains clinically valid and continues to be used in many countries, particularly where cost-effective treatment options are needed.

Licensed generic versions manufactured in FDA/EMA-approved facilities cost a small fraction of original branded prices. Here is how global access works through MedsPartner.

How does Sofosbuvir + Daclatasvir work - Mechanism of action

Hepatitis C virus survives by entering your liver cells and making copies. Sofosbuvir blocks NS5B - the tool the virus uses to copy its genetic material. If the virus cannot copy itself, it cannot spread inside the body. Sofosbuvir works against all major types of hepatitis C.

Daclatasvir blocks NS5A that helps the virus multiply and assemble new virus particles. 

When you use both medicines together, the dual attack makes the treatment very effective.

In clinical studies - about 90% of people who had never been treated before were cured,
and around 86% of people who had previous treatment were cured.

How much does Sofosbuvir/Daclatasvir cost - Branded vs generic options

Sovaldi remains available in the US market, though newer combination products like Harvoni and Epclusa have largely replaced standalone sofosbuvir therapy. These newer combinations still cost over for $20,000 a 12-week course.

MedsPartner's generic version of Sofosbuvir/Daclatasvir, manufactured by a FDA/EMA-approved facility in India, provides comparable benefits at a price that makes treatment accessible. The savings by switching to the generic version from MedsPartner are over 97%, with a 12-week treatment costing around $540.

Why do hepatitis C medicines cost so much?

When direct-acting antivirals first launched, prices were extremely high due to novelty. Over time, newer regimens replaced older combinations. Today, in many countries, hepatitis C treatment is broadly available through public programs as part of elimination efforts. But in other areas, even generics are steeply priced. Also, access is still uneven globally. In some regions, patients face coverage delays, high co-pays or limited availability of certain regimens. 

Through generics sourced from countries like India, full 12-week treatment courses can cost a few hundred dollars - far below original branded prices in various countries. Many patients go for this option through personal import.

Is it legal to import generic Sofosbuvir/Daclatasvir into my country?

Personal import is legal in most countries - when meds are not locally available or are unaffordable.

Requirements for legal personal import include a valid prescription from your doctor, confirmation that the medication is for your own treatment and purchase of limited quantities, (up to 3 months in most countries).

Country-specific rules differ. Some countries require advance notification to customs authorities. Others have specific document requirements for personal importation. MedsPartner specializes in navigating these regulations and ensures all shipments comply with destination country requirements.

We offer free consultations to review your local rules and determine the correct documentation needed for compliant importation.

How MedsPartner helped a patient in New Zealand access Sofosbuvir/Daclatasvir

In 2017 - Sally found out she had hepatitis C genotype 3. Her doctor recommended treatment with Sofosbuvir/Daclatasvir to prevent cirrhosis.

At the time, access to funded hepatitis C medicines in New Zealand was managed by PHARMAC. Funding criteria prioritized patients with more advanced liver fibrosis because of budget constraints during the early rollout of direct-acting antivirals.

Sally’s FibroScan showed early-stage disease. No significant scarring yet. Clinically, her doctor preferred to treat sooner rather than later. But she did not meet the threshold for publicly funded treatment.

After discussing it with her doctor, Sally chose to import a licensed generic version of sofosbuvir and daclatasvir through MedsPartner. The full 12-week course cost her about $540 and arrived within two weeks.

"They told me to wait until my liver got worse. That didn't make any medical sense. Getting the generic version meant I could get cured before serious damage happened" she said.

Answering your FAQs on Sofosbuvir/Daclatasvir and affordable access

Q1. My insurance denied coverage for hepatitis C meds - what are my options?

A - Insurance denials for hepatitis C treatment remain common, particularly for patients without advanced fibrosis. You can try filing an appeal with reports explaining the medical necessity of treatment. Organizations like the Patient Advocate Foundation may provide support. Gilead offers the Support Path program for commercially insured patients (excludes Medicare/Medicaid). When these options do not cover your situation, MedsPartner provides access to quality-assured generics at 97%+ savings.

Q2. How can I trust the quality of generic Sofosbuvir/Daclatasvir from MedsPartner?

A - MedsPartner sources sofosbuvir/daclatasvir exclusively from FDA/EMA-approved manufacturers after conducting strict quality checks. Generic medications demonstrate bioequivalence to branded products to receive approval. Each order includes manufacturer details and expiry dates. With 9 years of experience, 30,000+ successful deliveries across 40+ countries, and a 4.4-star Trustpilot rating, MedsPartner maintains a track record that patients and physicians rely on.

Q3. How does the personal import process work through MedsPartner?

A - Visit MedsPartner's Sofosbuvir/Daclatasvir page and upload your prescription showing the prescribed regimen and duration. Our team verifies prescription validity and checks your country's import regulations. We provide transparent pricing covering medication cost and shipping. After payment, we ship the medicine sourced from an FDA/EMA-approved manufacturer to your doorstep with all paperwork needed by customs. 

Q4. I'm a doctor - how do I help my patients get affordable sofosbuvir/daclatasvir?

A - Physicians can email support@medspartner.com with patient details and prescriptions. Our team will connect with the patient and ensure compliant personal import to their location according to local regulations. We offer full customer support throughout the process.

Q5. What are the side effects of sofosbuvir+daclatasvir?

A - Common side effects include headache, fatigue, nausea, and diarrhea. Most adverse effects are mild. Serious side effects are rare but include hepatitis B reactivation in patients with current or prior HBV infection. Your doctor will check your medical history and current treatment plan to prevent any adverse reactions.

Q6. How much can I save by using generic sofosbuvir/daclatasvir from MedsPartner?

A - In the United States today, most hepatitis C patients are treated with newer branded combinations such as Epclusa or Harvoni - which cost over $20,000 for a 12-week course. By comparison, MedsPartner’s generic sofosbuvir/daclatasvir costs $540 for a full 12-week course. That translates to potential savings of >97% for many patients.

The Cure Exists - The Price Doesn't Have to Stop You

Hepatitis C damages your liver quietly. Treating it early stops complications before they start. Direct-acting antivirals cure over 90% of patients. Twelve weeks of treatment offers a permanent cure. 

If cost or insurance restrictions are stopping you from getting treatment, get in touch or start your order by uploading your prescription. Reach out to our team on support@medspartner.com if you have any questions on how personal import of hepatitis C medicines works.

About the Author - Gunjan Agrawal brings deep experience in global healthcare logistics and cross-border medicine access. At MedsPartner - she oversees delivery of essential treatments to patients worldwide - ensuring safety, affordability & regulatory compliance. Her work draws on years of hands-on expertise in supplier management, quality assurance & international coordination - experience that has shaped her nuanced understanding of the real-world challenges in making healthcare truly accessible.